Skip to main content

Table 4 The description of signaling pathways related to NAFLD in the study

From: The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

KEGG ID & description

Target

False discovery rate

hsa04917: prolactin signaling pathway

ESR1, ESR2, GSK3B

0.0134

hsa04660: T cell receptor signaling pathway

FYN, IL2, GSK3B

0.0267

hsa04151: PI3K-Akt signaling pathway

VEGFA, IL2, GSK3B, NR4A1

0.0450